EBIT at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s EBIT?
- Inhibrx Biosciences, Inc. (INBX) reported EBIT of -$30.93M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s EBIT changed year-over-year?
- Inhibrx Biosciences, Inc.'s EBIT increased by 27.9% year-over-year, from -$42.9M to -$30.93M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s EBIT?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s EBIT has grown at a -21.5% compound annual growth rate (CAGR), from -$219.22M to -$135.03M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.